Dr. Rita S. Axelrod
Claim this profileThomas Jefferson University Hospital
Area of expertise
Lung Cancer
Rita S. Axelrod has run 3 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Rita S. Axelrod has run 2 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Thomas Jefferson University Hospital
Thomas Jefferson University, Sidney Kimmel Cancer Center
Clinical Trials Rita S. Axelrod is currently running
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting
1 award
Phase 2
19 criteria
Pre-Surgery Chemotherapy + Surgery & Radiation
for Sinus Cancer
This randomized phase II trial studies how well chemotherapy before surgery and radiation therapy works compared to surgery and radiation therapy alone in treating patients with nasal and paranasal sinus cancer that can be removed by surgery. Drugs used in chemotherapy, such as docetaxel, cisplatin, and carboplatin work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy before surgery and radiation therapy may make the tumor smaller and reduce the amount of normal tissue that needs to be removed and treated with radiation.
Recruiting
1 award
Phase 2
More about Rita S. Axelrod
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Rita S. Axelrod has experience with
- Docetaxel
- Carboplatin
- Pemetrexed
- Pembrolizumab
- Avelumab
- Cisplatin
Breakdown of trials Rita S. Axelrod has run
Lung Cancer
Endometrial Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rita S. Axelrod specialize in?
Rita S. Axelrod focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Rita S. Axelrod currently recruiting for clinical trials?
Yes, Rita S. Axelrod is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Rita S. Axelrod has studied deeply?
Yes, Rita S. Axelrod has studied treatments such as Docetaxel, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Rita S. Axelrod?
Apply for one of the trials that Rita S. Axelrod is conducting.
What is the office address of Rita S. Axelrod?
The office of Rita S. Axelrod is located at: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.